The crystal structure is shown in the gure. Tables 1-3 contain details of the measurement method and a list of the atoms including atomic coordinates and displacement parameters.
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Experimental details
Cell re nement and data reduction were carried out by Bruker SAINT and SHELXS-97 [16, 17] . The nitrogen bonded hydrogen atoms were re ned freely; all others were idealizes and re ned using a riding model (AFIX43, AFIX23 or AFIX137 option of the SHELX program [16] .
Discussion
The pyrimidine-2,4(1H,3H-dione (uracil) nucleus is a major pharmacophore in many chemotherapeutic agents. The chemotherapeutic e cacy of pyrimidine-related derivatives is related to their ability to inhibit vital enzymes responsible for DNA biosynthesis including dihydrofolate reductase (DHFR), thymidylate synthetase (TSase), thymidine phosphorylase (TPase) and reverse transcriptase (RTase). 1-[2-(Hydroxyethoxy)methyl]-6-(phenylthio)thymine (HEPT) and its derivatives have long been known for their potent activity against human immunode ciency viruses (HIV) [1] [2] [3] [4] [5] [6] [7] . In addition, numerous pyrimidine-related derivatives displayed marked activities against herpes simplex viruses (HSV) [8] , and hepatitis B viruses (HBV) [9] . Moreover, potent anticancer [10, 11] and antimicrobial activities [12] [13] [14] [15] were observed among several pyrimidine-2,4-dione derivatives. In the present investigation, we report the crystal structure of the title compound, which was proved to exhibit marked anti-HIV-1 activity [7] . The asymmetric unit of the crystal structure of title compound contains one molecule. There are two aromatic ring systems in title molecule: the tolyl ring (C7-C12) and the pyrimidine ring (C3/C4/N1/C5/N2/C6) attached to the sulphur atoms. The of these rings planes are almost perpendicular and make a dihedral angle of 88.94(3)°. The molecules packing in the crystal structure is stabilized via three intermolecular hydrogen bonds, of which the O1 and O2 act as hydrogen bond acceptors and N1, N2 and C9 act as hydrogen bond donors. The distance of the interactions between the N2-H1N2· · · O2 i , N1-H1N1· · · O1 ii and C9-H9A· · · O1 iii are 2.04(2), 2.00(2) and 2.47 Å, respectively, and the angles are 163(2), 169.7(19) and 146.0°, respectively. Symmetry codes: (i) -x+1, -y+1, -z+1; (ii) -x, -y, -z+1; (iii) x+1, y+1, z.
